September 15, 2022
TransCelerate Member Best Practice Sharing: Patient Technology Framework
Explore
September 15, 2022
Explore
September 13, 2022
This overview provides background on the PV Agreements Optimization (PVAO) initiative which seeks to produce a customizable, interactive resource for new and experienced contract partners, which could be used to inform and/or streamline their PVA process development, contract drafting, and negotiations.
Explore
June 3, 2022
22 Website Functionality proposed improvement opportunities TransCelerate highlighted in the RFI from 2021 to revamp the ClinicalTrials.gov website. In addition to describing what part of the website each proposed improvement opportunity falls under, you will also find the status of incorporation as well as any proposed next steps TransCelerate identified where appropriate.
Explore
May 17, 2022
The intention of the survey is to help answer the question: ‘What should sponsors and organizations who provide RWD for research purposes consider when preparing for audits in order to help establish relevance and reliability of RWD in a way that is meaningful to regulatory auditors?' from the perspective of organizations who provide RWD for research purposes.
Explore
May 6, 2022
TransCelerate Member shares their experience and best practices for the Clinical Study Report (CSR) and Lean Writing Principles
Explore
May 6, 2022
TransCelerate Member shares their experience and best practices for the Clinical Study Report (CSR) and Lean Writing Principles.
Explore
May 6, 2022
TransCelerate Member shares their experience and best practices for the Clinical Study Report (CSR) and Lean Writing Principles.
Explore
April 27, 2022
Explore
April 27, 2022
Provides an overview of the Diversity of Participants in Clinical Trials initiative and its available solutions.
Explore
February 14, 2022
This overview provides the background of the Privacy Methodology for Data Sharing initiative which is seeking to assist identify a model approach to implementing privacy safeguards that will provide increased transparency and enable simpler utilization of clinical trial data re-use.
Explore